Ina Research Inc
TSE:2176
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Ina Research Inc
Other Liabilities
Ina Research Inc
Other Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
I
|
Ina Research Inc
TSE:2176
|
Other Liabilities
¥54.1m
|
CAGR 3-Years
2%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-2%
|
|
|
Carna Biosciences Inc
TSE:4572
|
Other Liabilities
¥54.8m
|
CAGR 3-Years
11%
|
CAGR 5-Years
4%
|
CAGR 10-Years
8%
|
|
|
S
|
Shin Nippon Biomedical Laboratories Ltd
TSE:2395
|
Other Liabilities
¥2B
|
CAGR 3-Years
69%
|
CAGR 5-Years
157%
|
CAGR 10-Years
10%
|
|
|
Medinet Co Ltd
TSE:2370
|
Other Liabilities
¥239.3m
|
CAGR 3-Years
1%
|
CAGR 5-Years
2%
|
CAGR 10-Years
-6%
|
|
|
Immuno-Biological Laboratories Co Ltd
TSE:4570
|
Other Liabilities
¥18.2m
|
CAGR 3-Years
52%
|
CAGR 5-Years
28%
|
CAGR 10-Years
22%
|
|
|
D
|
DNA Chip Research Inc
TSE:2397
|
Other Liabilities
¥48.5m
|
CAGR 3-Years
68%
|
CAGR 5-Years
46%
|
CAGR 10-Years
32%
|
|
Ina Research Inc
Glance View
Ina Research, Inc. engages in the development of pharmaceutical products. The company is headquartered in Ina-Shi, Nagano-Ken and currently employs 194 full-time employees. The company went IPO on 2008-06-25. The firm operates in two business segments. The Contract Test segment is engaged in the provision of non-clinical test services to confirm the safety and efficacy of developed pharmaceuticals and food materials based on laboratory animals and cells for pharmaceutical development companies, food-related companies, research institutes and others. The Environmental segment is engaged in the design and sale of animal facilities for pharmaceutical companies and universities, deodorant-loaded devices, sterilization equipment, equipment for laboratory animals and others.
See Also
What is Ina Research Inc's Other Liabilities?
Other Liabilities
54.1m
JPY
Based on the financial report for Mar 31, 2022, Ina Research Inc's Other Liabilities amounts to 54.1m JPY.
What is Ina Research Inc's Other Liabilities growth rate?
Other Liabilities CAGR 10Y
-2%
Over the last year, the Other Liabilities growth was -6%. The average annual Other Liabilities growth rates for Ina Research Inc have been 2% over the past three years , 1% over the past five years , and -2% over the past ten years .
